# DESCRIPTION

## FIELD OF THE INVENTION

- introduce phthalimide derivatives of non-steroidal anti-inflammatory and/or TNF-α modulators

## BASIS OF THE INVENTION

- define inflammation
- describe acute and chronic inflammation
- discuss history of medicinal substances for pain and fever
- explain mechanism of NSAIDs
- describe COX-1 and COX-2 isoforms
- discuss limitations of COX-2 selective inhibitors
- highlight importance of TNF-α in inflammatory process
- discuss need for new therapeutic approaches

## SUMMARY OF THE INVENTION

- introduce phthalimide derivatives of NSAIDs for treating chronic inflammatory diseases

## Where:

- define NSAID and W
- define X

## DETAILED DESCRIPTION OF THE INVENTION

- motivate phthalimide derivatives of NSAIDs
- describe process for obtaining phthalimide derivatives
- describe pharmaceutical compositions and uses

## EXAMPLES

### Example 1

- synthesize compound N-(1,3-dioxy-1,3-dihydro-2H-isoindol-2-yl)-

### Example 2

- synthesize compound N-(1,3-dioxy-1,3-dihydro-2H-isoindol-2-yl)-

### Example 3

- synthesize compound N-(1,3-dioxy-1,3-dihydro-2H-isoindol-2-yl)
- synthesize compound N-(1,3-dioxy-1,3-dihydro-2H-isoindol-2-yl)

### Example 4

- synthesize compound 2-(3-benzoylphenyl)-N-(1,3-dioxy-1,3-dihydro-

### Example 5

- synthesize compound 2-{2-[(2,6-dichlorophenyl)amine]phenyl}-N-(1,3-d

### Example 6

- synthesize compound 2-{(2-[(2-chloro-6-fluorophenyl)amine]-5-methylphenyl

### Example 7

- synthesize hybrid derivatives of diclofenac

## Tests of the Rat Paw Edema Incuded by Carrageenin Utilizing The Compounds of the Invention Obtained in Examples 1.3, 2.3, 3.3, 5.3 and 6.3

- evaluate anti-inflammatory activity

## Example 8

### Test of Paw Edema Induced by Carrageenin with Pre-Treatment with the Compound N-(1,3-dioxy-1,3-dihydro-2H-isoindol-2-yl)-2-hydroxybenzamide (derivative from salicylic acid)

- evaluate anti-inflammatory activity

## Example 9

### Test of Paw Edema Induced by Carrageenin with pre-treatment with the compound N-(1,3-dioxy-1,3-dihydro-2H-isoindol-2-yl)-2-(4-isobutylphenl) propanamide

- evaluate anti-inflammatory activity

### Example 10

- evaluate anti-inflammatory activity

### Example 11

- evaluate anti-inflammatory activity

### Example 12

- evaluate anti-inflammatory activity

### Example 13

- evaluate gastric lesions
- classify ulceration
- compare with standard NSAIDs

### Example 14

- evaluate analgesic activity

### Methodologies Used for the Pharmacological Tests

- describe rat paws edema test
- describe gastric lesion test

